Otsuka is voluntarily recalling certain lots of ABILIFY® (aripiprazole) Tablets due to cross-contamination from extremely small amounts of another active pharmaceutical ingredient previously manufactured on the same equipment. Based on sample testing performed, there is no material patient risk associated with the trace level of contamination found. The voluntary recall has been initiated by Otsuka out of an abundance of caution, with the knowledge of the U.S. Food and Drug Administration. This recall is limited to the United States.

Consumers who have a product that is being recalled and who have concerns, should consult with their healthcare provider or pharmacy. Adverse reactions or quality problems experienced with the use of this product should be reported.

Otsuka America Pharmaceutical, Inc. can be reached by phone at 1-833-468-7852 Monday – Friday, 9 a.m. – 5 p.m. Eastern Time or by email: or The FDA's MedWatch Adverse Event Reporting program can be reached either online or by phone. To complete and submit the report Online: or call 1-800-332-1088.

Read more here:

April 2024 01US24EBC0008

With more than 20 years of experience leading marketing initiatives for some of the most well-known pharmaceutical brands, Louis is a seasoned executive known for invigorating teams with fresh ideas and positive motivation. Big ideas – and big success – come from proper planning and research, and Louis is able to connect the current business situation and goals, distilling the important facts into bite-sized achievable objectives to deliver decisive actions with maximum impact.

Louis has held several roles at Otsuka, starting at Vice President of Oncology Marketing and Sales before adding nephrology and medical devices to his portfolio of responsibilities. In his current role, Louis oversees Otsuka’s nephrology commercial franchise and commercial operations.

Prior to joining Otsuka, Louis served in various senior and executive roles responsible for oncology and urology marketing at Bayer Pharmaceuticals, Sanofi-Aventis, and Boehringer Ingelheim Pharmaceuticals, where he and his teams achieved success in developing and implementing best-in-class strategic marketing plans.

Louis earned his Master of Business Administration from the Quinnipiac University School of Business in Connecticut.

Otsuka perseveres to go where others are not willing—applying our courageous spirit to uncovering new solutions where there have not previously been options for those living with complex kidney disease.